首页> 外文期刊>RNA >The synergistic regulation of VEGF-mediated angiogenesis through miR-190 and target genes
【24h】

The synergistic regulation of VEGF-mediated angiogenesis through miR-190 and target genes

机译:通过miR-190和靶基因协同调节VEGF介导的血管生成

获取原文
获取原文并翻译 | 示例
           

摘要

VEGF is a major contributor to angiogenesis, a vital process in normal growth and development and tumor transition. However, the current clinical efficacy of VEGF inhibitors is limited, and the molecular mechanism underlying VEGF regulation remains to be elucidated. Here we show that miR-190 directly targets a group of angiogenic effectors besides VEGF per se. Noted, these effectors can transcriptionally regulate VEGF expression in an intracellular or intercellular manner, thus demonstrating that miR-190 modulates the VEGF-mediated tumor angiogenesis at three levels. The synergistic effect of miR-190 and its target genes demonstrates a complex but apparently more stable system, allowing for the tight control of the level of VEGF. Finally, we showed that miR-190 significantly suppresses tumor metastasis, especially angiogenesis. Together, these results indicate that miR-190 is a promising antitumor target in clinical applications.
机译:VEGF是血管生成的主要成分,血管生成是正常生长发育和肿瘤转移的重要过程。但是,目前VEGF抑制剂的临床疗效是有限的,而VEGF调控的分子机制尚待阐明。在这里,我们显示miR-190除VEGF本身外还直接靶向一组血管生成效应子。注意,这些效应子可以细胞内或细胞间方式转录调节VEGF的表达,从而证明miR-190在三个水平上调节VEGF介导的肿瘤血管生成。 miR-190及其靶基因的协同作用显示出一个复杂但显然更稳定的系统,可以严格控制VEGF的水平。最后,我们证明了miR-190可显着抑制肿瘤转移,尤其是血管生成。总之,这些结果表明,miR-190在临床应用中是有希望的抗肿瘤靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号